Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0156
+0.0004 (2.63%)
Oct 22, 2025, 5:27 PM CET
2.63%
Market Cap765.74K
Revenue (ttm)2.00K
Net Income (ttm)1.96M
Shares Out50.38M
EPS (ttm)0.40
PE Ratio0.04
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume472,587
Average Volume638,119
Open0.0158
Previous Close0.0152
Day's Range0.0146 - 0.0158
52-Week Range0.0142 - 0.3445
Beta0.52
RSI31.97
Earnings DateOct 14, 2025

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 11
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.